Fatigue Severity Scale (FSS)
Click the buttons provided below to view information contained in a specific part of this record:
|
General Information
|
| Objectives |
|
To evaluate fatigue in multiple sclerosis and other conditions including Chronic Fatigue Immune Dysfunction Syndrome (CFIDS) and Systemic Lupus Erythmatosis (SLE).
|
|
| Category of Outcome Measure |
|
| Chronology of Development |
|
The FSS was designed to differentiate fatigue from clinical depression, both of which share some of the same symptoms.
|
|
| Mode of Assessment |
Self administered on site
Self administered off site
|
|
| Age Group |
Adults (16 Years and Over)
|
|
| Conditions of Use and Contact Information |
|
|
|
Questionnaire/Scale
|
| Domain Name / Number of Items |
|
| Additional Format Information |
|
|
| Total Score |
Yes - total score is calculated.
|
|
| Total Score - Range/Direction |
|
1 to 7 (low value indicates that the statement is not very appropriate whereas a high value indicates agreement)
|
|
| Sub-Score |
No - sub-score is not calculated.
|
|
| Sub-Score Range/Direction |
|
Scores for each item are added together and divided by 9 to calculate the average response.
|
|
|
|
|
Reference 1
|
| Other Information |
|
This is the PROQOLID webpage for the FSS. It contains summary information about FSS and links to other related information.
|
|
|
|
|
Reference 2
|
| Reference Details |
|
Luc Laberge, Yves Dauvilliers, Paul Bégin, Louis Richer, Stéphane Jean, Jean Mathieu.; (2009) Fatigue and daytime sleepiness in patients with myotonic dystrophy type 1: To lump or split?; Neuromuscular Disorders; June; Vol. 19; Iss. 6; pp 397-402
|
|
|
|
